These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27974860)

  • 1. A Novel Microfluidic Assay for Rapid Phenotypic Antibiotic Susceptibility Testing of Bacteria Detected in Clinical Blood Cultures.
    Malmberg C; Yuen P; Spaak J; Cars O; Tängdén T; Lagerbäck P
    PLoS One; 2016; 11(12):e0167356. PubMed ID: 27974860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid antibiotic susceptibility testing by tracking single cell growth in a microfluidic agarose channel system.
    Choi J; Jung YG; Kim J; Kim S; Jung Y; Na H; Kwon S
    Lab Chip; 2013 Jan; 13(2):280-7. PubMed ID: 23172338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multiplex Fluidic Chip for Rapid Phenotypic Antibiotic Susceptibility Testing.
    Wistrand-Yuen P; Malmberg C; Fatsis-Kavalopoulos N; Lübke M; Tängdén T; Kreuger J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.
    Kassim A; Omuse G; Premji Z; Revathi G
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():21. PubMed ID: 27068515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICy: a Novel Flow Cytometric Method for Rapid Determination of Minimal Inhibitory Concentration.
    Kállai A; Kelemen M; Molnár N; Tropotei A; Hauser B; Iványi Z; Gál J; Ligeti E; Kristóf K; Lőrincz ÁM
    Microbiol Spectr; 2021 Dec; 9(3):e0090121. PubMed ID: 34878335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the WST-8 colorimetric method and the CLSI broth microdilution method for susceptibility testing against drug-resistant bacteria.
    Tsukatani T; Suenaga H; Shiga M; Noguchi K; Ishiyama M; Ezoe T; Matsumoto K
    J Microbiol Methods; 2012 Sep; 90(3):160-6. PubMed ID: 22642794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial action of a heat-stable form of L-amino acid oxidase isolated from king cobra (Ophiophagus hannah) venom.
    Lee ML; Tan NH; Fung SY; Sekaran SD
    Comp Biochem Physiol C Toxicol Pharmacol; 2011 Mar; 153(2):237-42. PubMed ID: 21059402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoliter-Sized Microchamber/Microarray Microfluidic Platform for Antibiotic Susceptibility Testing.
    Azizi M; Zaferani M; Dogan B; Zhang S; Simpson KW; Abbaspourrad A
    Anal Chem; 2018 Dec; 90(24):14137-14144. PubMed ID: 30474959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafast Parallelized Microfluidic Platform for Antimicrobial Susceptibility Testing of Gram Positive and Negative Bacteria.
    Kang W; Sarkar S; Lin ZS; McKenney S; Konry T
    Anal Chem; 2019 May; 91(9):6242-6249. PubMed ID: 30938989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro anti-microbial susceptibility of clinical isolates of pathogenic bacteria to ten antibiotics including phosphomycin.
    Eke PI; Rotimi VO
    Afr J Med Med Sci; 1987 Mar; 16(1):1-8. PubMed ID: 3037870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
    Buyck JM; Peyrusson F; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4750-8. PubMed ID: 26014952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trend in the susceptibility of the most frequent bacterial pathogens isolated at Hospital General La Mancha Centro over 2010-2012 period].
    Asencio MÁ; Huertas M; Carranza R; Franco M; Castellanos J; Barberá JR; Conde Mdel C; Tenías JM
    Rev Esp Quimioter; 2014 Dec; 27(4):261-8. PubMed ID: 25536430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of bacteria isolated from patients with lower respiratory tract infections to antibiotics (1987)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Kondou T; Saitou A; Matsumiya H; Ueda K; Terai T
    Jpn J Antibiot; 1990 Jan; 43(1):147-80. PubMed ID: 2112206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility testing of grown blood cultures by combining culture and real-time polymerase chain reaction is rapid and effective.
    Beuving J; Verbon A; Gronthoud FA; Stobberingh EE; Wolffs PF
    PLoS One; 2011; 6(12):e27689. PubMed ID: 22194790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.